Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Oxidative and inflammatory status in Type 2 diabetes patients with periodontitis.

Allen EM, Matthews JB, O' Halloran DJ, Griffiths HR, Chapple IL.

J Clin Periodontol. 2011 Oct;38(10):894-901. doi: 10.1111/j.1600-051X.2011.01764.x. Epub 2011 Aug 24.

PMID:
21883360
2.

Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes.

Chen L, Wei B, Li J, Liu F, Xuan D, Xie B, Zhang J.

J Periodontol. 2010 Mar;81(3):364-71. doi: 10.1902/jop.2009.090544.

PMID:
20192862
3.
4.

Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study.

Chen L, Luo G, Xuan D, Wei B, Liu F, Li J, Zhang J.

J Periodontol. 2012 Apr;83(4):435-43. doi: 10.1902/jop.2011.110327. Epub 2011 Aug 22.

PMID:
21859323
5.

Superoxide dismutase activity in gingiva in type-2 diabetes mellitus patients with chronic periodontitis.

Akalin FA, Işiksal E, Baltacioğlu E, Renda N, Karabulut E.

Arch Oral Biol. 2008 Jan;53(1):44-52. Epub 2007 Sep 18.

PMID:
17880913
6.

Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent.

Lirussi F, Beccarello A, Zanette G, De Monte A, Donadon V, Velussi M, Crepaldi G.

Diabetes Nutr Metab. 2002 Aug;15(4):222-31.

PMID:
12416659
7.

Health behaviour, metabolic control and periodontal status in medically treated Chinese with type 2 diabetes mellitus.

Leung WK, Movva LR, Wong MC, Corbet EF, Siu SC, Kawamura M.

Ann R Australas Coll Dent Surg. 2008 Jun;19:102-10.

PMID:
22073462
8.

Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis.

Kardeşler L, Buduneli N, Cetinkalp S, Kinane DF.

J Periodontol. 2010 Jan;81(1):24-33. doi: 10.1902/jop.2009.090267.

PMID:
20059414
9.

Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects.

Rytter E, Vessby B, Asgård R, Johansson C, Sjödin A, Abramsson-Zetterberg L, Möller L, Basu S.

Br J Nutr. 2009 May;101(10):1423-6.

PMID:
19459227
10.
11.

Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus.

Al-Shoumer KA, Al-Asousi AA, Doi SA, Vasanthy BA.

Ann Saudi Med. 2008 Sep-Oct;28(5):367-70.

12.

Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.

Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu D, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC; ADOPT Study Group.

Diabetes. 2006 Aug;55(8):2357-64.

13.

Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.

Derosa G, Cicero AF, Scalise F, Avanzini MA, Tinelli C, Piccinni MN, Peros E, Geroldi D, Fogari E, D'Angelo A.

Endothelium. 2007 Jan-Feb;14(1):45-51.

PMID:
17364896
14.

Levels of inflammatory markers and their correlation with dyslipidemia in diabetics.

Waheed P, Naveed AK, Farooq F.

J Coll Physicians Surg Pak. 2009 Apr;19(4):207-10. doi: 04.2009/JCPSP.207210.

PMID:
19356332
15.

Association between plasma high-sensitivity C-reactive protein and insulin resistance and white matter lesions in Japanese type 2 diabetic patients.

Anan F, Masaki T, Kikuchi H, Iwao T, Shimomura T, Umeno Y, Eshima N, Saikawa T, Yoshimatsu H.

Diabetes Res Clin Pract. 2010 Feb;87(2):233-9. doi: 10.1016/j.diabres.2009.10.017. Epub 2009 Nov 20.

PMID:
19931932
16.

Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment.

Makiura N, Ojima M, Kou Y, Furuta N, Okahashi N, Shizukuishi S, Amano A.

Oral Microbiol Immunol. 2008 Aug;23(4):348-51. doi: 10.1111/j.1399-302X.2007.00426.x.

PMID:
18582336
17.

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group.

Coron Artery Dis. 2001 Aug;12(5):413-23.

PMID:
11491207
18.

High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.

Dullaart RP, de Vries R, Sluiter WJ, Voorbij HA.

Clin Endocrinol (Oxf). 2009 Feb;70(2):221-6. doi: 10.1111/j.1365-2265.2008.03306.x.

PMID:
18505467
19.

C-peptide and its correlation to parameters of insulin resistance in the metabolic syndrome.

Banu S, Jabir NR, Manjunath CN, Shakil S, Kamal MA.

CNS Neurol Disord Drug Targets. 2011 Dec;10(8):921-7.

PMID:
22229322
20.

Meal testing and postprandial state of type 2 diabetic patients with metabolic syndrome.

Brădescu OM, Georgescu M, Ifrim S, Ioacără S, Ionescu-Tîrgovişte C.

Rom J Intern Med. 2005;43(1-2):97-113.

PMID:
16739870

Supplemental Content

Support Center